Position in ADVB
as of Sep 30, 2025
· filed Nov 14, 2025
Position Value
$62,500
+$22,133 QoQ
Shares Held
6,976
+142.0% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADVB Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,695,022,750 across 34 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
574,992 | $288,277,988 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
1,193,601 | $270,696,770 | |
| 3 | GH |
Guardant Health, Inc.
|
1,449,534 | $217,473,585 | |
| 4 | DHR |
Danaher Corp /De/
|
943,694 | $179,754,833 | |
| 5 | RVTY |
Revvity, Inc.
|
1,457,335 | $162,143,091 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,101,501 | $146,312,377 | |
| 7 | NTRA |
Natera, Inc.
|
265,607 | $72,099,020 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
865,462 | $59,413,965 |
All Filings in ADVB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 | $62,500 | 139,511 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $40,367 | 57,668 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,954 | 11,213 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||